Acute Myeloid Leukemia

The main activities of EHA AML SWG is aiming for, are:

  • Organization of the Annual scientific meeting at EHA.
  • To institute a platform for translational research.
  • To provide a forum to bridge gaps between basic scientists and clinicians treating patients with AML.
  • Consideration of the implications of high throughput sequencing technologies and minimal residual disease assessment in clinical trial design.
  • Close collaboration with ELN AML WP 5; for example, by developing Guidelines / Recommendations.
  • Instrumental for developing pan European trials.

Become a registered member of this Scientific Working Group: Apply here

Highlights from the SWG

Chairs and Members

SWG Educational Activities

Publications